INS and diabetes mellitus: The advantages of pioglitazone therapy, which include better sensitivity to insulin and management of diabetes mellitus, are weighed against its side effects, which include increased body weight, retention of fluids, a decrease in bone density, and a potential rise in bladder cancer [5,44].